Carzomib Carfilzomib 60 mg Injection

Carfilzomib 60 mg injection is a prescription-only oncology injectable supplied as a sterile, single-use vial for intravenous administration by qualified healthcare professionals. Marketed under the brand name Carzomib, this formulation contains Carfilzomib, a selective proteasome inhibitor used within regulated oncology treatment protocols. Carfilzomib 60 mg injection is manufactured for hospital and institutional use and is supplied strictly for international pharmaceutical export by AmeriDrugs.

Active Ingredient

• Carfilzomib – 60 mg per vial
  Carfilzomib is a second-generation proteasome inhibitor used in specialized oncology settings under approved regulatory frameworks.

Therapeutic Category

From a regulatory and informational standpoint, Carfilzomib 60 mg injection is categorized as an antineoplastic injectable used in hematological oncology. All clinical decisions, treatment protocols, and patient administration are determined solely by licensed medical professionals in accordance with local laws. AmeriDrugs does not provide medical advice or treatment recommendations related to Carfilzomib 60 mg injection.

Dosage Form & Administration

• Lyophilized powder for injection

• Single-use vial

• For intravenous use only

• Reconstitution and administration performed by trained healthcare professionals

• Dosage and infusion schedule determined by institutional oncology protocols

Manufacturing & Quality Standards

Carfilzomib 60 mg injection (Carzomib) is manufactured in GMP-compliant facilities with validated sterile processing systems. Each batch undergoes rigorous quality control to ensure identity, potency, sterility, and consistency in line with international pharmaceutical export requirements.

Packaging Details

• Strength: 60 mg per vial

• Single-use vial with secure closure

• Export-grade secondary packaging

• Labeling compliant with prescription injectable oncology medicines

Intended Buyers

This product is supplied exclusively to:

• Licensed pharmaceutical distributors

• Oncology hospitals and cancer treatment centers

• Government and private healthcare procurement agencies

• Authorized international pharmaceutical importers

Carfilzomib 60 mg injection is not intended for retail sale, online consumer purchase, or direct patient distribution.

Regulatory Disclaimer

Carfilzomib 60 mg injection (Carzomib) is a prescription-only oncology medicine. Importation, storage, distribution, and use must comply with the pharmaceutical and injectable drug regulations of the destination country. AmeriDrugs operates strictly as an export-oriented pharmaceutical supplier and does not promote off-label use or self-medication.